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Abstract
Background—Expression of the neuronal membrane glycoprotein M6a (GPM6A), the 
proteolipid protein (PLP/DM20) family member, is downregulated in the hippocampus of 
chronically stressed animals. Its neuroplastic function involves a role in neurite formation, 
filopodium outgrowth and synaptogenesis through an unknown mechanism. Disruptions in 
neuroplasticity mechanisms have been shown to play a significant part in the etiology of 
depression. Thus, the current investigation examined whether GPM6A expression is also altered in 
human depressed brain.
Methods—Expression levels and coexpression patterns of GPM6A, GPM6B, and PLP1 (two 
other members of PLP/DM20 family) as well as of the neuroplasticity-related genes identified to 
associate with GPM6A were determined using quantitative polymerase chain reaction (qPCR) in 
postmortem samples from the hippocampus (n =18) and the prefrontal cortex (PFC) (n= 25) of 
depressed suicide victims and compared with control subjects (hippocampus n= 18; PFC n =25). 
Neuroplasticity-related proteins that form complexes with GPM6A were identified by 
coimmunoprecipitation technique followed by mass spectrometry.
Results—Results indicated transcriptional downregulation of GPM6A and GPM6B in the 
hippocampus of depressed suicides. The expression level of calcium/calmodulin-dependent 
protein kinase II alpha (CAMK2A) and coronin1A (CORO1A) was also significantly decreased. 
Subsequent analysis of coexpression patterns demonstrated coordinated gene expression in the 
hippocampus and in the PFC indicating that the function of these genes might be coregulated in 
the human brain. However, in the brain of depressed suicides this coordinated response was 
disrupted.
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Conclusions—Disruption of coordinated gene expression as well as abnormalities in GPM6A 
and GPM6B expression and expression of the components of GPM6A complexes were detected in 
the brain of depressed suicides.
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INTRODUCTION
Neuroplasticity is the mechanism by which information is stored and maintained within 
individual synapses, neurons, and neuronal circuits to guide organism behavior. Several 
lines of evidence demonstrate impairment of neuroplasticity in depression (Pittenger and 
Duman, 2008; Christoffel et al., 2011). For example, in patients with different types of 
depression, the hippocampus and the prefrontal cortex (PFC) are both reduced in size and 
activity, and alterations in synaptic and morphological plasticity have been reported 
(Rajkowska et al., 1999; Stockmeier et al., 2004; Drevets et al., 2008; Pittenger and Duman, 
2008; Kang et al., 2012). The histopathological correlates include reductions in synapses or 
synaptic proteins, reductions in neuronal size, and in neuropil (Drevets et al., 2008). Similar 
alterations have been observed in animal models of chronic stress: reductions in dendritic 
arborizations and a loss of highly specialized dendritic spines and synapses in regions that 
appear homologous to the areas where reductions are evident in depressed humans (i.e., 
PFC, hippocampus) (McKittrick et al., 2000; Radley et al., 2004; Drevets et al., 2008; 
Pittenger and Duman, 2008). The intracellular mechanisms underlying these alterations and 
their relevance to human depression are poorly understood.
The neuronal membrane glycoprotein M6a (GPM6A), a member of the myelin proteolipid 
protein (PLP/DM20) family, has been shown to play a role in stress response in different 
animal models (Alfonso et al., 2004a,b; Cooper et al., 2009; Monteleone et al., 2014). For 
example, chronic social and physical stress decreases Gpm6a mRNA levels in the 
hippocampus, and this downregulation is prevented by administration of antidepressants 
(Alfonso et al., 2004b, 2006). An association of the GPM6A gene with a depression 
subgroup of schizophrenia patients (Boks et al., 2008) as well as a critical role of GPM6A 
expression levels for cognitive function have been reported recently (Gregor et al., 2014). 
Gpm6a knockout mouse model is viable and shows no gross malformations or behavioral 
abnormalities (El-Kordi et al., 2013). However, after mild social stress by single housing, 
these mice displayed a claustrophobia-like phenotype. Interestingly, in humans a 3′UTR 
variant of GPM6A has been linked to claustrophobia in two pedigrees (El-Kordi et al., 
2013).
Apart from Gpm6a, other members of the family, the closely related Gpm6b and Dm20 
(Plp1 transcript variant), but not Plp1 itself, have been shown to be downregulated by 
chronic stress (Fernandez et al., 2010). Remarkably, the myelin proteolipid protein (PLP/
DM20) family members, such as GPM6A, GPM6B, and PLP1 transcript variant DM20, but 
not PLP1 (Fernandez et al., 2010), have been shown to be involved in the processes of 
neurite outgrowth and filopodium formation (Lagenaur et al., 1992; Mukobata et al., 2002; 
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Alfonso et al., 2005; Michibata et al., 2008; Zhao et al., 2008; Fuchsova et al., 2009; Brocco 
et al., 2010; Scorticati et al., 2011). GPM6A, in particular, is also required for filopodium 
motility and synaptogenesis (Fuchsova et al., 2009; Brocco et al., 2010), and it has been 
implicated in neuronal differentiation of human stem cells (Michibata et al., 2009) and PC12 
cells (Mukobata et al., 2002). When siRNA methodology is used, GPM6A low-expressing 
neurons display decreased filopodia numbers and a lower density of synaptophysin clusters 
(Alfonso et al., 2005).
Neurite growth and remodeling, as well as filopodium and spine formation, represent 
fundamental processes during neuroplasticity. Thus, we hypothesized that alterations in the 
expression of the stress responsive neuroplasticity-related genes such as the members of the 
PLP family could suggest that the cellular pathways that involve these genes are sensitive to 
disease condition. This would result in dysregulation of neuroplasticity mechanisms 
involved in the etiology of this disease. Therefore, we examined in the present study the 
expression of PLP family members GPM6A, GPM6B, and PLP1 in the hippocampus (n=18) 
and the PFC (n=25) of depressed suicides. The mechanisms and signaling pathways that 
mediate GPM6A neuroplastic effects are still unknown. Thus, we also identified the 
neuroplasticity-related proteins that form complexes with GPM6A and examined their 
expression as well.
EXPERIMENTAL PROCEDURES
Subjects
The study was performed in PFC (Brodmann area 9) samples from suicide (n=25) and 
matched nonpsychiatric control subjects (n=25). Brain tissues from the same cohort have 
been used previously in various studies published by our group (Dwivedi et al., 2008; 
Dwivedi et al., 2009, 2010; Pandey et al., 2014). Dissected regions of interest included 
predominantly cortical gray matter. The white matter was removed as much as possible, but 
there was still some white matter left. Hippocampi were available for 18 suicide subjects and 
18 nonpsychiatric controls. Postmortem brain samples were obtained from the Maryland 
Brain Collection at the Maryland Psychiatric Research Center, Baltimore. Tissues were 
collected only after a family member gave informed consent. Brain samples were free of 
neuropathologic abnormalities or human immunodeficiency virus antibodies. Toxicological 
data were obtained by an analysis of urine and blood samples. Psychiatric diagnoses in 
suicide and control subjects were evaluated with the Diagnostic Evaluation After Death 
(Salzman et al., 1983) and the Structured Clinical Interview for DSM-IV (Spitzer et al., 
1995). Family members gave permission for clinical records to be obtained from mental 
health treatment providers in all cases of suicide. Control subjects were verified to be free 
from mental illnesses using a consensus diagnostic procedure. All procedures were approved 
by the Institutional Review Board of the University of Illinois at Chicago. Detailed 
demography of subjects is provided in Table 1.
RNA isolation and reverse transcription
Total RNA was extracted from 100 mg of tissue using the Trizol® (Invitrogen, Carlsbad, 
California) according to the manufacturer’s directions. RNA concentration and purity were 
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determined by measuring the OD A260/A280 and A260/A230 using NanoDrop®ND-1000 
(NanoDrop Technologies, Montchanin, Delaware). All samples were free of contaminants 
with absorbance ratios close to two. RNA quality was assessed using Agilent Bioanalyzer 
2100. All samples had 28S/18S ratios >1.2 and RNA integrity number (RIN) above 6.6. 
First-strand cDNA was synthesized from 1 μg of total RNA using MMLV-reverse 
transcriptase (Invitrogen) in the presence of random hexamers (2.5 μM) (Invitrogen) 
according to manufacturer’s instructions.
Oligonucleotide primers
Primer Express 3.0 software (Applied Biosystems, Foster City, CA, USA) was used to 
design primers for the amplification of human GPM6A, GPM6B, PLP1, CORO1A, GIT1, 
CAMK2A, BDNF and five candidate internal reference genes (GAPDH, YWHAZ, CYC1, 
PPIA, and EIF4A2). Primer sequence, full gene name, accession number, function, and 
chromosomal localization are listed in Table 2 (reference genes) and Table 3 (target genes).
Quantitative polymerase chain reaction (qPCR)
To determine mRNA levels, qPCR reactions were performed using SYBR®Select Master 
Mix (Applied Biosystems) according to the manufacturer’s instructions. Measurements were 
done on Stratagene Mx3005P equipped with MxPro software (Stratagene, La Jolla, CA, 
USA). All reactions were performed in duplicate. No-RT control, no-template control and 
three different inter-run calibrators were always included for each individual plate and gene 
assay. After the final cycle of PCR, reactions were subjected to a heat dissociation protocol 
to verify primer specificity. A single peak corresponding to the melting temperature (Tm) of 
expected qPCR assay product was observed for all pairs of primers assayed (Fig. 1C). 
Reproducibility of the reverse transcription (RT) reaction and inter-run reproducibility of 
qPCR was evaluated by measuring twice the expression of GPM6A and PPIA in eight 
randomly selected samples as shown in the Fig. 1A (reproducibility of two independent RT 
reactions) and 1B (reproducibility of two independent qPCR runs) (Fig. 1A, B). Relative 
expression levels, reported as fold change (FC), were determined by the relative standard 
curve method as described in the Applied Biosystems Guide to Performing Relative 
Quantitation of Gene Expression using Real-Time Quantitative PCR. Standard curves were 
constructed using 10-fold serial dilutions of cDNA derived from all subjects and the linear 
range and PCR reaction efficiency of each gene assay were determined. All gene assays 
were found to have r2 ≥ 0.988 and efficiencies between 90 and 110 percent (Fig. 1C). Raw 
expression data (CT values) were analyzed by qBasePLUS software (Biogazelle, 
Zwijnaarde, Belgium). Data are normalized to the normalization factor calculated as a 
geometric mean of the expression of three reference genes and normalized values are used 
for further statistical analysis (Vandesompele et al., 2002). Outliers were excluded before 
analysis if the normalized values were greater than two standard deviations from the group 
mean.
Determination of reference targets for qPCR data normalization
The algorithm geNorm of qBasePLUS software was used to evaluate expression stability of 
reference genes used for qPCR data normalization as described (Vandesompele et al., 2002). 
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Gene stability of five candidates (EIF4A2, YWHAZ, GAPDH, CYC1, and PPIA) was 
evaluated. Special attention was paid to selecting genes that belong to different functional 
classes, which significantly reduces the chance that genes might be coregulated (see the 
Table 2 for full gene name, accession number, function, chromosomal localization, and 
primer sequences).
The reference targets PPIA, CYC1, and GAPDH were determined as the most stably 
expressed genes and the optimum number of three reference candidates was found adequate 
for the optimal normalization of data in our experimental setting (Fig. 2A–C). Fig. 2D shows 
that control and suicide samples did not differ with respect to GAPDH, CYC1 and PPIA 
mRNA expression levels. The geometric mean of GAPDH, CYC1, and PPIA was further 
used for normalization in all relative quantitation assays.
Immunoprecipitation (IP) and mass spectrometry
Hippocampal tissue from a two-month-old female Wistar rat was dissected and collected in 
lysis buffer (150 mM NaCl, 50 mM Tris/HCl, 1% deoxycholate sodium salt, 0.1% SDS, pH 
8) supplemented with protease inhibitor cocktail (Sigma–Aldrich, St Louis, MO, USA) to 
prepare the protein extract. The precleared protein extract was then incubated with the 
polyclonal antibody against the C-terminus of rat GPM6A developed in our laboratory 
(Fernandez and Frasch, unpublished results) covalently bound to Protein A–Sepharose via 
dimethyl pimelimidate (Sigma–Aldrich) as described (Harlow and Lane, 1988). As a 
control, non-immune rabbit serum was used. Alkylation of the samples to block cysteine 
residues was performed by treatment with iodoacetamide (Sigma–Aldrich) at the final 
concentration of 20 mM. The immunoprecipitates were analyzed by SDS–PAGE followed 
either by Western blotting or by mass spectrometry. In the second case, polyacrylamide gels 
were silver stained by the mass spectrometry compatible staining method. Only specifically 
bound proteins not detectable in control immunoprecipitates were excised from the gel, 
subjected to tryptic digest and analyzed by mass spectrometry.
Peptide sequencing
In order to obtain internal peptide sequences, in-gel tryptic digestion was performed as 
described (Hellman et al., 1995), peptides were separated using reversed-phase HPLC in a 
150-mm × 1-mm Kromasil C18 column, and sequenced in an Applied Biosystems, model 
494 A Procise Automatic Sequencer (Applied Biosystems), run according to the 
manufacturer’s instructions.
Matrix-assisted laser desorption-ionization time-of-flight-MS (MALDI-TOF-MS)
MALDI-TOF-MS was performed on a Bruker Autoflex, operated for analysis of intact 
proteins in linear mode and externally calibrated with trypsinogen (23.98 kDa), protein A 
(44.61 kDa) and BSA (66.43 kDa). Prior toanalysis, the sample was desalted by micro-
reversed-phase chromatography. The crystals were prepared by the double-layer technique 
using sinapinic acid as matrix. For peptide mass fingerprinting, tryptic digests were analyzed 
using a dried droplet preparation with alfa-cyano 4-hydroxy cinnamic acid as matrix. 
Calibration was done internally, with autolytic peptides from the porcine trypsin used for 
digestion. The manufacturer’s instructions were followed, and the resulting peptide mass 
FUCHSOVA et al. Page 5
Neuroscience. Author manuscript; available in PMC 2016 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
lists were used to scan the latest NCBInr sequence database for protein identity using the 
search engine ProFound.
Plasmid transfection, SDS–PAGE, and Western blot
COS7 cells cultured in Dulbecco’s modified Eagle’s medium with 10% (v/v) fetal bovine 
serum, penicillin, and streptomycin were transfected with plasmids encoding a green 
fluorescent protein (GFP) or a fusion protein GPM6A-GFP using Lipofectamine®2000 
(Invitrogen) following the manufacturer’s instructions. Twenty-four hours later, cells were 
lysed and the protein samples for SDS–PAGE were prepared as described (Fuchsova et al., 
2009). The protein samples were separated on 10% SDS–PAGE gels and transferred to a 
nitro-cellulose membrane by electroblotting. The membranes were blocked in Tris-buffered 
saline containing 5% nonfat dried milk and incubated with the rabbit anti-GFP polyclonal 
serum (1/750) (Invitrogen) or with the polyclonal anti-GPM6A antibody (1/400) developed 
in our laboratory. Antigen–antibody complexes were detected using an anti-rabbit 
horseradish peroxidase-linked secondary antibody (1/10,000) (Dako, Glostrup, Denmark) 
according to standard Enhanced Chemiluminescence protocol using SuperSignal West Pico/
Femto chemiluminescent substrate (Pierce, Rockford, IL, USA).
Statistical analysis
Data were analyzed by analysis of covariance (ANCOVA) independently for each brain 
region and gene of interest to compare control subjects and depressed suicide victims 
adjusting the effects of age, postmortem interval (PMI), and brain pH. For multiple 
comparisons, Bonferroni correction to maintain alpha at 0.05 was used to adjust the type I 
error rates. Results are reported as individual values and group mean±SD. For correlation 
analysis of mRNA expression levels, pairwise Pearson correlation coefficients along with its 
95% confidence intervals, and p value (two-tailed) were calculated on normalized mRNA 
expression levels. Pearson correlation values p<0.05 were considered significant. Chi-square 
analyses were conducted to determine whether the frequency of significant correlations 
differed between groups. Statistical analysis and graphs were done with GraphPad Prism 
software.
RESULTS
Demographic characteristics
Detailed demographic characteristics of suicide and control subjects are provided in Table 1. 
The age range of suicide subjects and controls was between 22 and 74 years, and the PMI 
was between 5 and 31 h. There were no significant differences between suicide subjects and 
their matched controls in age (p=0.8292, unpaired t-test, two-tailed) or PMI (p=0.2132, 
unpaired t-test, two-tailed). The mean brain pH±SD in controls was 7.01±0.15 and in 
suicides was 7.00±0.14, which was not significantly different (p=0.8436, unpaired t-test, 
two-tailed). The mean RIN±SD in the PFC was 7.21±0.56 in the control group and 
7.23±0.61 in the depressed group. In the hippocampus, the mean RIN±SD was 7.16±0.72 in 
the control group and 7.45±0.83 in the depressed group. There was no difference in RIN 
values between controls and depressed suicide subjects in both the PCF and the 
hippocampus (p=0.7 and p=0.37; respectively, unpaired t-test, two-tailed).
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GPM6A expression is downregulated in the hippocampus of depressed suicides
To determine whether the altered expression of GPM6A is associated with the 
pathophysiology of human depression, its mRNA level was measured in the entire cohort by 
qPCR. Stress responsiveness and cellular function is conserved among the members of the 
PLP/DM20 family (Fernandez et al., 2010). Thus, we also examined GPM6B and PLP1 
expression.
Fig. 3A, B show mRNA levels of GPM6A, GPM6B, and PLP1 in the PFC (Fig. 3A) and in 
the hippocampus (Fig. 3B) of depressed suicides and matched non-psychiatric controls. In 
the PFC, no significant differences were observed between the control and depressed groups 
for any of the members. On the other hand, F-test of ANCOVA showed that in the 
hippocampus, the mean GPM6A mRNA level was significantly decreased in the depressed 
group (F=14.55, p=0.0002, FC=0.82). Closely related GPM6B also demonstrated a 
significant decrease (F=12.98, p=0.0005, FC =0.80) and no changes were observed for 
PLP1.
As a control, we evaluated the expression of BDNF because the decreased BDNF mRNA 
level in postmortem PFC and hippocampus of depressed suicides has been reported 
frequently in the past (Dwivedi et al., 2003; Duman and Monteggia, 2006). As expected, 
BDNF mRNA levels were significantly decreased in the depressed subjects compared with 
controls in both the PCF and the hippocampus (F=16.39, p=0.0001, FC=0.79, and F=12.65, 
p=0.0006, FC=0.64; respectively) (Fig. 2E). The age, PMI and brain pH had no significant 
effects on mRNA expressions of GPM6A, GPM6B, and PLP1.
Coronin1A (CORO1A), calcium/calmodulin-dependent protein kinase II alpha (CAMK2A), 
and GIT1 co-immunoprecipitate with the stress-responsive glycoprotein GPM6A
To identify the underlying molecular mechanism through which GPM6A affects neuronal 
remodeling and plasticity, we searched for proteins that associate with GPM6A. For this 
purpose, first, the polyclonal antibody against the C-terminus of GPM6A was developed and 
purified. Western blot in the Fig. 4A shows that the anti-GPM6A antibody recognizes the 
endogenous GPM6A (~35 kDa) in the lysate from rat hippocampus (Hipp; 1st lane) and the 
exogenous GPM6A overexpressed as a GFP-fusion protein (~62 kDa) in non-neuronal cell 
line COS7 (3rd lane). No signal was detected when COS7 were transfected with GFP alone 
(2nd lane). The polyclonal anti-GFP antibody recognizes both GPM6A-GFP and GFP when 
overexpressed in COS7 cells (4th–5th lane; respectively).
Subsequently, immunoprecipitation of the endogenous GPM6A from the rat hippocampal 
lysate was performed using the anti-GPM6A antibody covalently coupled to protein A-
Sepharose (Fig. 4B, lane 2). As a control, non-immune rabbit serum covalently coupled to 
protein A-Sepharose was used (Fig. 4B, lane 1). Using mass spectrometry, GPM6A protein 
was correctly identified in the immunoprecipitate. In addition, among other proteins, 
cytoskeleton- and neuroplasticity-related proteins, such as GIT1, CORO1A, and CAMK2A, 
were identified to coimmunoprecipitate with GPM6A (Fig. 4B, arrows; see the table in the 
Fig. 4C for the complete list of identified proteins).
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Altered expression of CORO1A, GIT1, and CAMK2A in the postmortem brain of depressed 
suicides
Next, we evaluated whether the expression of the genes encoding the proteins identified to 
form complexes with GPM6A (namely GIT1, CORO1A, and CAMK2A) is altered in the 
postmortem brain of depressed suicide subjects. Fig. 5 shows mRNA levels of CORO1A, 
GIT1, and CAMK2A in the PFC (Fig. 5A) and in the hippocampus (Fig. 5B) of depressed 
suicides and matched non-psychiatric controls.
For CORO1A and CAMK2A, our ANCOVA analysis showed significant differences between 
the depressed and the control group in the hippocampus (F=25.45, p<0.0001, FC=0.73, and 
F=18.47, p<0.0001, FC=0.70; respectively). We did not observe any significant changes for 
CORO1A and CAMK2A in the PFC. Expression of GIT1 mRNA did not differ in either of 
the tissues. The age, PMI and brain pH had no significant effects on mRNA expressions of 
CORO1A, CAMK2A, and GIT1.
Coordinated expression
To determine whether interrelationships existed among the GPM6A levels and GIT1, 
CORO1A, and CAMK2A expression, and among the expression of the two other members of 
PLP/DM20 family—GPM6B and PLP1—cross-correlation analyses were conducted 
independently for each brain region among the depressed suicides and in the control group. 
This type of analysis allows us to detect coordinated changes in gene expression if the 
pathway is affected by disease. Pearson correlation coefficients and p values were calculated 
for all genes on normalized mRNA expression levels for the control group and the 
depression group separately in the PFC and in the hippocampus.
Fig. 6A shows correlation matrices where statistically significant Pearson correlation p 
values are indicated by asterisks. In both the hippocampus and the PFC of control 
individuals, significant interrelationships were frequent. Specifically, in the control PFC, 9 
of 15 possible correlations were statistically significant. Within the hippocampus of control 
individuals, 7 of 15 correlations were statistically significant. The correlations evident in 
controls differed from the correlations that were significant in the suicide brain. The 
reduction of correlations was observed in the PFC, where only five correlations were 
significant, as well as in the hippocampus, where the number of significant correlations 
declined to one. In the hippocampus, the difference in the frequency of significant 
correlations between the depressed suicide group and the control group was statistically 
significant (chi-square=6.136, p=0.0132).
Fig. 6B depicts the network of the gene coexpression patterns in the control and depressed 
groups to illustrate our findings. In both tissues of the control group, correlated genes 
formed an extensive inter-connected network, suggesting they function in common signaling 
cascades. In the depressed group, this coordinated gene expression is considerably altered in 
the PFC and notably, it completely disappears in the hippocampus, where the only 
correlation detected was between GPM6A and CORO1A.
FUCHSOVA et al. Page 8
Neuroscience. Author manuscript; available in PMC 2016 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Effect of psychotropic drugs and gender
Since several subjects in the depressed suicide group were on antidepressant medication at 
the time of death and/or suffered from comorbid substance abuse, we examined if the 
presence of psychotropic drugs had any influence on the mRNA expression of studied 
genes. In the depressed suicide group, there were 14 subjects who were on different types of 
antidepressants and seven subjects who were free of any psychotropic medication. When we 
compared the mRNA expression of studied genes, we did not find any significant 
differences between these two groups, suggesting that the presence of antidepressants did 
not have a significant influence on the expression of GPM6A, GPM6B, CORO1A, PLP1, 
GIT1, and CAMK2A. Thus, the differences in the GPM6A, GPM6B, CORO1A, and 
CAMK2A expression in the hippocampus between the depressed suicide group and normal 
controls do not appear to be related to the presence of psychotropic drugs.
To assess the effect of gender on gene expression we analyzed the data by a two-way 
ANOVA independently for each brain region with diagnosis and gender as categorical 
independent variables adjusting the effects of age, PMI, and brain pH. The only gene 
expression where a significant gender by diagnosis interaction was revealed was GPM6B 
expression in the PFC (F=8.31, p=0.0062). No effect on GPM6B expression was detected in 
the hippocampus. To further investigate this gender by diagnosis effect on GPM6B 
expression in PFC, we conducted ANCOVA analysis on males and females separately. A 
significant decrease in the GPM6B expression was observed in depressed male subjects 
(F=10.63, p=0.0016) but not in female subjects.
DISCUSSION
In our previous studies, we showed that chronic stress, a factor with a clear role in the 
etiology of depression, reduces the hippocampal mRNA levels of PLP/DM20 family 
members in animal models of chronic psychosocial or physical stress (Alfonso et al., 2004b, 
2006). In the present work, we demonstrate that, GPM6A mRNA levels are significantly 
reduced in the hippocampus of depressed suicides. Moreover, the closely related GPM6B, 
but not PLP1, is downregulated.
Previous studies by in situ hybridization have indicated that PLP1, the major component of 
myelin sheets, is expressed in glial cells but not neurons, GPM6B is expressed in glial cells 
and neurons, whereas GPM6A is restricted to the latter (Yan et al., 1996). Extensive 
evidence supports the misfunction of oligodendrocytes in major depression. Among other 
alterations, reduced oligodendrocyte numbers in amygdala and PFC have been observed and 
downregulation of oligodendrocyte-related gene transcripts has been reported in the brain of 
depressed subjects in regions including the amygdala and PFC (Edgar and Sibille, 2012). In 
addition, PLP1 itself was shown to be downregulated in the temporal cortex of depressed 
subjects (Aston et al., 2005). Taking into account the overlap of the functions of PLP1 and 
GPM6B in developmental myelination (Jahn et al., 2009; Werner et al., 2013), we could 
hypothesize that reduced GPM6B expression might participate in oligodendrocyte 
misfunction associated with depression even though the PLP1 expression was not altered in 
our study.
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Chronic stress induces profound behavioral changes in humans and rodents, manifested as 
depressive-like symptoms, a hyperanxious state, and learning/memory deficits, paralleled by 
structural damage and impaired synaptic plasticity, mainly in the hippocampus and PFC 
(Pittenger and Duman, 2008). Stress-induced functional deficits have been shown to 
propagate from a hippocampus-dependent task to a PFC-dependent task (Cerqueira et al., 
2007). We could speculate that region-specific downregulation of PLP family member genes 
in the hippocampus may reflect a region’s vulnerability to the diseases and involvement of 
their gene products in underlying disruptions of hippocampus-dependent tasks (Pittenger 
and Duman, 2008). For example, GPM6A potential involvement in the hippocampus-
dependent memory would be in agreement with the impaired long-term memory 
performance of M6 (GPM6A ortholog in fly)-deficient and overexpressing flies (Gregor et 
al., 2014) and identification of de novo duplication of GPM6A in a patient with learning 
disability. In fly, M6 shows particularly strong expression in the fly mushroom body (Zappia 
et al., 2012), which is important for learning and memory processes in Drosophila (McGuire 
et al., 2001). Another potential mechanism involved in observed region-specific effects 
could be neurogenesis known to play a critical role in the pathophysiology of depression. 
Findings by Michibata et al. (2008) suggest that expression level of GPM6A is directly or 
indirectly associated with the differentiation of neurons derived from undifferentiated 
embryonic stem cells. However, the involvement of PLP1 family members in adult 
neurogenesis has not been explored at the moment.
GPM6A functions in processes of neuronal remodeling and plasticity, such as neurite 
outgrowth, filopodium formation, and synaptogenesis (Alfonso et al., 2005; Fuchsova et al., 
2009; Brocco et al., 2010; Scorticati et al., 2011). Its overexpression induces neurite 
formation and increases filopodia density in hippocampal neurons. Similarly, GPM6B and 
DM20, but not PLP1, induce filopodium formation in primary hippocampal neurons 
(Fernandez et al., 2010).
Dendrites, dendritic filopodia (precursors to spine synapses), and spines are crucial 
components for synaptic function and plasticity. Changes in their density or morphological 
features can result in significant alterations in the connectivity of neural systems (Segal, 
2005; Chen et al., 2007) and would be expected to result in changes in the neurobehavioral 
functions subserved by those systems. We suppose that the reduction in GPM6A expression 
in the depressed suicide brain might be related to the morphological alterations found in the 
brain of depressed humans.
Synapses between neurons can change functionally and structurally in response to activity in 
a process known as synaptic plasticity. Apart from alterations in structural plasticity, 
disruptions in functional synaptic plasticity have also been reported in depression. Among 
the molecules implicated in synaptic plasticity, CAMK2A has been established as an 
enzyme of central importance (Lisman et al., 2002; Zhang et al., 2008; Lucchesi et al., 
2011). Previous studies have suggested the involvement of CAMK2 in the pathophysiology 
of psychiatric conditions, including bipolar disorder (Xing et al., 2002), Alzheimer disease 
(Amada et al., 2005), schizophrenia, and depression (Novak et al., 2006) as well as in the 
mechanism of action of antidepressants (Lisman et al., 2002; Celano et al., 2003; Tiraboschi 
et al., 2004; Barbiero et al., 2007; Lucchesi et al., 2011). CAMK2A is expressed postnatally 
FUCHSOVA et al. Page 10
Neuroscience. Author manuscript; available in PMC 2016 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
during brain maturation and stabilizes dendritic arbor structure (Wu and Cline, 1998). It is 
the most abundant protein in the postsynaptic density (PSD) (Cheng et al., 2006), where the 
activated CAMK2A phosphorylates AMPA receptors and other PSD proteins, which likely 
contributes to enhancement of synaptic strength (Lisman et al., 2002). In our study, 
CAMK2A has been identified as one of the proteins that form complexes with GPM6A. 
Moreover, we observed significantly lower CAMK2A expression in the hippocampus of 
depressed suicides. We hypothesize that the observed downregulation of CAMK2A could 
decrease the potential for synaptic plasticity in agreement with reductions in neuroplasticity 
in depression. Other findings show that synaptic CAMK2A targeting depends on an intact F-
actin cytoskeleton (Jalan-Sakrikar et al., 2012). Indeed, actin is essential for functional and 
structural plasticity and specific mechanisms of cytoskeleton regulation are integral to the 
processes of neuronal remodeling (Hotulainen and Hoogenraad, 2010; Svitkina et al., 2010). 
These pathways mainly converge on the Rho family of small GTPases such as RhoA, Rac1, 
or Cdc42. In line with these observations, the other two proteins that we identified as 
components of GPM6A complexes are CORO1A and GIT1. CORO1A belongs to a family 
of WD40 domain-containing proteins that control diverse aspects of F-actin polymerization 
and branching cycle. It binds filamentous actin, Arp2/3 complex (Chan et al., 2011) and 
regulates the plasma membrane localization and activation of Rac1 (Castro-Castro et al., 
2011). On the other hand, GIT1 functions as an integrator of signaling pathways controlling 
vesicle trafficking, adhesion, and cytoskeletal organization. It also regulates spine 
morphogenesis and synapse formation by targeting actin regulators and locally modulating 
Rac activity at synapses (Zhang et al., 2003, 2005; Webb et al., 2007). Here, we observed 
that CORO1A, but not GIT1 expression is downregulated in the hippocampus in the 
depressed group. Our findings are consistent with the previously described role of structural 
plasticity in depression (Christoffel et al., 2011). The pathway analyses of gene ontology 
groups commonly identify structural plasticity- and cytoskeleton-related signaling pathways 
as being highly modulated by stress and depression-like behavioral paradigms (Piubelli et 
al., 2011; Andrus et al., 2012). Furthermore, genetic association studies among individuals 
with lifetime depression have shown that a pathway consisting of genes that regulate 
cytoskeletal dynamics significantly associates with anhedonic depression (van Veen et al., 
2012).
Gene products that function together in common signaling cascades or protein complexes 
are expected to show greater similarities in their expression patterns than random sets of 
gene products (Vidal et al., 2011). Indeed, in the present study we observe significant 
correlations among the expression levels of GPM6A, GPM6B, CORO1A, GIT1, and 
CAMK2A, but not PLP1 in the hippocampus of control subjects. Positive significant 
correlations are also observed among GPM6B, CORO1A, GIT1, and CAMK2A in the PFC. 
Here, in addition, negative correlations among GPM6A, CORO1A, GIT1, CAMK2A, and 
PLP1 are detected. These observations support the fact that these gene products might be co-
regulated in the hippocampus and PFC of humans. And although further studies are needed 
to define detailed mechanisms of interactions of GPM6A with these proteins and will be 
described elsewhere (B Fuchsova and AC Frasch, unpublished results), we suggest that the 
neuroplastic function of GPM6A in filopodia and neurite outgrowth could be mediated by 
signaling pathways that involve GIT1, CORO1A, and/or CAMK2A.
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Notably, we observed that the coordinated gene expression is disrupted or reorganized in 
depressed suicides. In the hippocampus, the only significant correlation detected is between 
GPM6A and CORO1A and, in the PFC considerable alterations compared to the control 
group are observed. Various studies have applied gene coexpression network analysis to 
associate coexpression modules with psychiatric diseases, providing important insights into 
the pathways disbalanced in the disease (Merali et al., 2004; Poulter et al., 2010; Zhurov et 
al., 2012; Gaiteri et al., 2014). Our findings are in agreement with observations that 
pathological mechanisms leading to depression may affect the coordination of gene 
expression in the brain (Merali et al., 2004; Gaiteri et al., 2010, 2014; Poulter et al., 2010; 
Zhurov et al., 2012). This may reflect dysregulation of gene expression and loss of 
coordinated transcriptional response, although observed changes may i result from other 
regulatory processes such as altered mRNA stability or microRNA actions.
Depression and stress may lead to the downregulation of our targets genes and their 
functional consequences through different mechanisms. Epigenetic mechanisms could be a 
possible explanation since GPM6A has been identified as a novel target for epigenetic 
regulation during prenatal stress through changes in methylation status and in 
posttranscriptional regulation by microRNAs. GPM6A mRNA expression has been shown 
to be modulated by miR-133b (Monteleone et al., 2014) and by miR-124 (El-Kordi et al., 
2013). Interestingly, miR-133b expression is modulated by prenatal stress exposure in rats 
both in the hippocampus and PFC (Monteleone et al., 2014). Whether miR-133b and/or 
miR-124 regulate GPM6A expression in major depression remains to be established. Since 
one miRNA can target several mRNAs, dysregulation of one or just a few miRNAs could 
cause differential expression of a wide network of genes, as observed in complex 
pathologies such as depression (Dwivedi, 2014). Another possible mechanism could involve 
posttranscriptional regulation similar to what is observed for PLP1 transcript in 
schizophrenia patients (Aberg et al., 2006). It has been shown that QKI, an RNA-binding 
protein previously identified as a new candidate gene for schizophrenia, modulates mRNA 
levels of human oligodendrocyte-related genes, including PLP1, in schizophrenia patients 
through disturbance in its splicing (Aberg et al., 2006). It would be interesting to evaluate 
association of QKI with depression as well as its involvement in modulation of mRNA 
stability of other members of the PLP family.
Major depressive disorder and other neuropsychiatric disorders are complex diseases 
implicating a large number of genes. Each of them confers a small and incremental risk that 
potentially converges in dysregulated biological pathways, cellular functions, local circuit 
changes, and, eventually scales up to brain region pathophysiology (Belmaker and Agam, 
2008). Even if differential expression is low or absent, the genetics of complex disease can 
led to alterations in the molecular interactions of cellular pathways. Thus, changes in gene–
gene correlation may occur and their collective effect may become clear through the 
coexpression networks (Gaiteri et al., 2014). In this context, changes in coexpression 
network structure can help to identify candidate disease genes. For example, Rhinn et al. 
identified a novel mechanism for the alpha synuclein regulation in the context of 
Parkinson’s disease pathology by using differential coexpression to prioritize disease-related 
molecular targets. The alpha synuclein variant aSynL, containing a long 3′UTR, was 
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identified as the most differentially coexpressed gene in several Parkinson’s disease 
datasets; however, aSynL was not among the most differentially expressed transcripts 
between patients and controls (Rhinn et al., 2012) and thus would have likely been over-
looked by traditional analysis. From this point of view, we consider the loss of coordinated 
expression in our study of high interest. It suggests that the cellular pathways that involve 
studied genes are sensitive to disease condition. As for the mechanistic insight, it is tempting 
to speculate that as a consequence of their altered coexpression, GPM6A morphogenetic 
function in neurite outgrowth, filopodium formation and synaptogenesis as well as the 
synaptic plasticity function of CAMK2A and CORO1A would be affected with 
consequences for neuronal remodeling and connectivity. This would fit with the 
observations that dendritic complexity and synapse density are reduced in depression 
(Drevets et al., 2008).
The conclusions that can be drawn on the basis of the present investigation are subject to 
several limitations. Among other things, our cohort is confounded by the fact that the 
samples come from those who committed suicide. Although all individuals that had died by 
suicide had a history of depression (depressed phase in case of bipolar disorder), it is not 
necessarily the case that the present findings are generalizable to depression where suicidal 
intent was not present, nor is it the case that suicide itself was without effect (van Heeringen, 
2001). Recent studies by Turecki and others have shown that there may be gene expression 
patterns that are associated with suicidality (Sequeira et al., 2007, 2009) albeit with some 
overlap in those associated with major depression. Thus, our findings may be relevant to 
suicidality and/or depression. Moreover, follow-up studies are necessary to determine the 
impact on the protein levels of studied genes. Despite these limitations, we consider that the 
observed alterations in mRNA levels and disturbance in coordinated gene expression of the 
neuroplasticity-related genes represent an important contribution in relation to the efforts of 
identifying potential candidates associated with mental illness. The observed changes in the 
balance between mRNA levels of studied genes might result in significant alterations in the 
neuronal connectivity between brain regions resulting in pathological behaviors.
In the future, global assessment of changes in gene expression would be of great value to 
help us to identify key molecular networks associated with depression. For example, high-
throughput RNAseq detects both coding and noncoding RNAs, is superior for gene network 
construction, detects alternative spliced transcripts, detects allele-specific expression and can 
be used to extract genotype information, e.g. nonsynonymous coding single nucleotide 
polymorphisms. In this sense, it could allow us to look at the system as a whole thus 
deepening our understanding of such complex diseases such as depression.
CONCLUSION
Disruption of coordinated gene expression and abnormalities in mRNA expression of 
GPM6A, GPM6B and components of GPM6A protein complexes were detected in the brain 
of depressed suicides.
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ANCOVA analysis of covariance
CAMK2A calcium/calmodulin-dependent protein kinase II alpha
CORO1A coronin1A
FC fold change
GFP green fluorescent protein
GPM6A neuronal membrane glycoprotein M6a
PFC prefrontal cortex
PLP proteolipid protein
PMI postmortem interval
qPCR quantitative polymerase chain reaction
RT reverse transcription
References
Aberg K, Saetre P, Jareborg N, Jazin E. Human QKI, a potential regulator of mRNA expression of 
human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci U S A. 2006; 
103:7482–7487. [PubMed: 16641098] 
Alfonso J, Aguero F, Sanchez DO, Flugge G, Fuchs E, Frasch AC, Pollevick GD. Gene expression 
analysis in the hippocampal formation of tree shrews chronically treated with cortisol. J Neurosci 
Res. 2004a; 78:702–710. [PubMed: 15505804] 
Alfonso J, Fernandez ME, Cooper B, Flugge G, Frasch AC. The stress-regulated protein M6a is a key 
modulator for neurite outgrowth and filopodium/spine formation. Proc Natl Acad Sci U S A. 2005; 
102:17196–17201. [PubMed: 16286650] 
Alfonso J, Frick LR, Silberman DM, Palumbo ML, Genaro AM, Frasch AC. Regulation of 
hippocampal gene expression is conserved in two species subjected to different stressors and 
antidepressant treatments. Biol Psychiatry. 2006; 59:244–251. [PubMed: 16140276] 
Alfonso J, Pollevick GD, Van Der Hart MG, Flugge G, Fuchs E, Frasch AC. Identification of genes 
regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. Eur J 
Neurosci. 2004b; 19:659–666. [PubMed: 14984416] 
Amada N, Aihara K, Ravid R, Horie M. Reduction of NR1 and phosphorylated Ca2+/calmodulin-
dependent protein kinase II levels in Alzheimer’s disease. Neuroreport. 2005; 16:1809–1813. 
[PubMed: 16237332] 
Andrus BM, Blizinsky K, Vedell PT, Dennis K, Shukla PK, Schaffer DJ, Radulovic J, Churchill GA, 
Redei EE. Gene expression patterns in the hippocampus and amygdala of endogenous depression 
and chronic stress models. Mol Psychiatry. 2012; 17:49–61. [PubMed: 21079605] 
FUCHSOVA et al. Page 14
Neuroscience. Author manuscript; available in PMC 2016 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and 
oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. 
Mol Psychiatry. 2005; 10:309–322. [PubMed: 15303102] 
Barbiero VS, Giambelli R, Musazzi L, Tiraboschi E, Tardito D, Perez J, Drago F, Racagni G, Popoli 
M. Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II 
between presynaptic compartments. Neuropsychopharmacology. 2007; 32:2511–2519. [PubMed: 
17356571] 
Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008; 358:55–68. [PubMed: 
18172175] 
Boks MP, Hoogendoorn M, Jungerius BJ, Bakker SC, Sommer IE, Sinke RJ, Ophoff RA, Kahn RS. 
Do mood symptoms subdivide the schizophrenia phenotype? Association of the GMP6A gene 
with a depression subgroup. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B:707–711. 
[PubMed: 18163405] 
Brocco MA, Fernandez ME, Frasch AC. Filopodial protrusions induced by glycoprotein M6a exhibit 
high motility and aids synapse formation. Eur J Neurosci. 2010; 31:195–202. [PubMed: 
20074218] 
Castro-Castro A, Ojeda V, Barreira M, Sauzeau V, Navarro-Lerida I, Muriel O, Couceiro JR, 
Pimentel-Muinos FX, Del Pozo MA, Bustelo XR. Coronin 1A promotes a cytoskeletal-based 
feedback loop that facilitates Rac1 translocation and activation. EMBO J. 2011; 30:3913–3927. 
[PubMed: 21873980] 
Celano E, Tiraboschi E, Consogno E, D’Urso G, Mbakop MP, Gennarelli M, de Bartolomeis A, 
Racagni G, Popoli M. Selective regulation of presynaptic calcium/calmodulin-dependent protein 
kinase II by psychotropic drugs. Biol Psychiatry. 2003; 53:442–449. [PubMed: 12614997] 
Cerqueira JJ, Mailliet F, Almeida OF, Jay TM, Sousa N. The prefrontal cortex as a key target of the 
maladaptive response to stress. J Neurosci. 2007; 27:2781–2787. [PubMed: 17360899] 
Chan KT, Creed SJ, Bear JE. Unraveling the enigma: progress towards understanding the coronin 
family of actin regulators. Trends Cell Biol. 2011; 21:481–488. [PubMed: 21632254] 
Chen LY, Rex CS, Casale MS, Gall CM, Lynch G. Changes in synaptic morphology accompany actin 
signaling during LTP. J Neurosci. 2007; 27:5363–5372. [PubMed: 17507558] 
Cheng D, Hoogenraad CC, Rush J, Ramm E, Schlager MA, Duong DM, Xu P, Wijayawardana SR, 
Hanfelt J, Nakagawa T, Sheng M, Peng J. Relative and absolute quantification of postsynaptic 
density proteome isolated from rat forebrain and cerebellum. Mol Cell Proteomics. 2006; 5:1158–
1170. [PubMed: 16507876] 
Christoffel DJ, Golden SA, Russo SJ. Structural and synaptic plasticity in stress-related disorders. Rev 
Neurosci. 2011; 22:535–549. [PubMed: 21967517] 
Cooper B, Fuchs E, Flugge G. Expression of the axonal membrane glycoprotein M6a is regulated by 
chronic stress. PLoS One. 2009; 4:e3659. [PubMed: 19180239] 
Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: 
implications for neurocircuitry models of depression. Brain Struct Funct. 2008; 213:93–118. 
[PubMed: 18704495] 
Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 
2006; 59:1116–1127. [PubMed: 16631126] 
Dwivedi Y. Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic 
implications. Dialogues Clin Neurosci. 2014; 16:43–61. [PubMed: 24733970] 
Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression 
of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide 
subjects. Arch Gen Psychiatry. 2003; 60:804–815. [PubMed: 12912764] 
Dwivedi Y, Rizavi HS, Teppen T, Zhang H, Mondal A, Roberts RC, Conley RR, Pandey GN. Lower 
phosphoinositide 3-kinase (PI 3-kinase) activity and differential expression levels of selective 
catalytic and regulatory PI 3-kinase subunit isoforms in prefrontal cortex and hippocampus of 
suicide subjects. Neuropsychopharmacology. 2008; 33:2324–2340. [PubMed: 18075493] 
Dwivedi Y, Rizavi HS, Zhang H, Roberts RC, Conley RR, Pandey GN. Aberrant extracellular signal-
regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1). Int J 
Neuropsychopharmacol. 2009; 12:1337–1354. [PubMed: 19835659] 
FUCHSOVA et al. Page 15
Neuroscience. Author manuscript; available in PMC 2016 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Dwivedi Y, Rizavi HS, Zhang H, Roberts RC, Conley RR, Pandey GN. Modulation in activation and 
expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-
dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in 
postmortem brain of suicide subjects. Biol Psychiatry. 2010; 67:1017–1025. [PubMed: 20163786] 
Edgar N, Sibille E. A putative functional role for oligodendrocytes in mood regulation. Transl 
Psychiatry. 2012; 2:e109. [PubMed: 22832953] 
El-Kordi A, Kastner A, Grube S, Klugmann M, Begemann M, Sperling S, Hammerschmidt K, 
Hammer C, Stepniak B, Patzig J, de Monasterio-Schrader P, Strenzke N, Flugge G, Werner HB, 
Pawlak R, Nave KA, Ehrenreich H. A single gene defect causing claustrophobia. Transl 
Psychiatry. 2013; 3:e254. [PubMed: 23632458] 
Fernandez ME, Alfonso J, Brocco MA, Frasch AC. Conserved cellular function and stress-mediated 
regulation among members of the proteolipid protein family. J Neurosci Res. 2010; 88:1298–1308. 
[PubMed: 19937804] 
Fuchsova B, Fernandez ME, Alfonso J, Frasch AC. Cysteine residues in the large extracellular loop 
(EC2) are essential for the function of the stress-regulated glycoprotein M6a. J Biol Chem. 2009; 
284:32075–32088. [PubMed: 19737934] 
Gaiteri C, Ding Y, French B, Tseng GC, Sibille E. Beyond modules and hubs: the potential of gene 
coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes 
Brain Behav. 2014; 13:13–24. [PubMed: 24320616] 
Gaiteri C, Guilloux JP, Lewis DA, Sibille E. Altered gene synchrony suggests a combined hormone-
mediated dysregulated state in major depression. PLoS One. 2010; 5:e9970. [PubMed: 20376317] 
Gregor A, Kramer JM, van der Voet M, Schanze I, Uebe S, Donders R, Reis A, Schenck A, Zweier C. 
Altered GPM6A/M6 dosage impairs cognition and causes phenotypes responsive to cholesterol in 
human and drosophila. Hum Mutat. 2014; 35:1495–1505. [PubMed: 25224183] 
Harlow, E.; Lane, D. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor 
Laboratory; 1988. Coupling antibodies to protein A beads; p. 521-523.
Hellman U, Wernstedt C, Gonez J, Heldin CH. Improvement of an “In-Gel” digestion procedure for 
the micropreparation of internal protein fragments for amino acid sequencing. Anal Biochem. 
1995; 224:451–455. [PubMed: 7710111] 
Hotulainen P, Hoogenraad CC. Actin in dendritic spines: connecting dynamics to function. J Cell Biol. 
2010; 189:619–629. [PubMed: 20457765] 
Jahn O, Tenzer S, Werner HB. Myelin proteomics: molecular anatomy of an insulating sheath. Mol 
Neurobiol. 2009; 40:55–72. [PubMed: 19452287] 
Jalan-Sakrikar N, Bartlett RK, Baucum AJ 2nd, Colbran RJ. Substrate-selective and Calcium-
independent Activation of CaMKII by alpha-Actinin. J Biol Chem. 2012; 287:15275–15283. 
[PubMed: 22427672] 
Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A, Majik MS, 
Jeong LS, Banasr M, Son H, Duman RS. Decreased expression of synapse-related genes and loss 
of synapses in major depressive disorder. Nat Med. 2012; 18:1413–1417. [PubMed: 22885997] 
Lagenaur C, Kunemund V, Fischer G, Fushiki S, Schachner M. Monoclonal M6 antibody interferes 
with neurite extension of cultured neurons. J Neurobiol. 1992; 23:71–88. [PubMed: 1564456] 
Lisman J, Schulman H, Cline H. The molecular basis of CaMKII function in synaptic and behavioural 
memory. Nat Rev Neurosci. 2002; 3:175–190. [PubMed: 11994750] 
Lucchesi W, Mizuno K, Giese KP. Novel insights into CaMKII function and regulation during 
memory formation. Brain Res Bull. 2011; 85:2–8. [PubMed: 21070840] 
McGuire SE, Le PT, Davis RL. The role of Drosophila mushroom body signaling in olfactory 
memory. Science. 2001; 293:1330–1333. [PubMed: 11397912] 
McKittrick CR, Magarinos AM, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR. Chronic social 
stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin 
transporter sites. Synapse. 2000; 36:85–94. [PubMed: 10767055] 
Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H. Dysregulation in the 
suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) 
receptor subunits in frontal cortical brain region. J Neurosci. 2004; 24:1478–1485. [PubMed: 
14960621] 
FUCHSOVA et al. Page 16
Neuroscience. Author manuscript; available in PMC 2016 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Michibata H, Okuno T, Konishi N, Kyono K, Wakimoto K, Aoki K, Kondo Y, Takata K, Kitamura Y, 
Taniguchi T. Human GPM6A is associated with differentiation and neuronal migration of neurons 
derived from human embryonic stem cells. Stem Cells Dev. 2009; 18:629–639. [PubMed: 
19298174] 
Michibata H, Okuno T, Konishi N, Wakimoto K, Kyono K, Aoki K, Kondo Y, Takata K, Kitamura Y, 
Taniguchi T. Inhibition of mouse GPM6A expression leads to decreased differentiation of neurons 
derived from mouse embryonic stem cells. Stem Cells Dev. 2008; 17:641–651. [PubMed: 
18522499] 
Monteleone MC, Adrover E, Pallares ME, Antonelli MC, Frasch AC, Brocco MA. Prenatal stress 
changes the glycoprotein GPM6A gene expression and induces epigenetic changes in rat offspring 
brain. Epigenetics. 2014; 9:152–160. [PubMed: 23959066] 
Mukobata S, Hibino T, Sugiyama A, Urano Y, Inatomi A, Kanai Y, Endo H, Tashiro F. M6a acts as a 
nerve growth factor-gated Ca(2+) channel in neuronal differentiation. Biochem Biophys Res 
Commun. 2002; 297:722–728. [PubMed: 12359212] 
Novak G, Seeman P, Tallerico T. Increased expression of calcium/calmodulin-dependent protein 
kinase IIbeta in frontal cortex in schizophrenia and depression. Synapse. 2006; 59:61–68. 
[PubMed: 16247765] 
Pandey GN, Rizavi HS, Ren X, Bhaumik R, Dwivedi Y. Toll-like receptors in the depressed and 
suicide brain. J Psychiatr Res. 2014; 53:62–68. [PubMed: 24565447] 
Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. 
Neuropsychopharmacology. 2008; 33:88–109. [PubMed: 17851537] 
Piubelli C, Carboni L, Becchi S, Mathe AA, Domenici E. Regulation of cytoskeleton machinery, 
neurogenesis and energy metabolism pathways in a rat gene-environment model of depression 
revealed by proteomic analysis. Neuroscience. 2011; 176:349–380. [PubMed: 21195137] 
Poulter MO, Du L, Zhurov V, Palkovits M, Faludi G, Merali Z, Anisman H. Altered Organization of 
GABA(A) Receptor mRNA Expression in the Depressed Suicide Brain. Front Mol Neurosci. 
2010; 3:3. [PubMed: 20407580] 
Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR, McEwen BS, Morrison JH. Chronic 
behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial 
prefrontal cortex. Neuroscience. 2004; 125:1–6. [PubMed: 15051139] 
Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, 
Stockmeier CA. Morphometric evidence for neuronal and glial prefrontal cell pathology in major 
depression. Biol Psychiatry. 1999; 45:1085–1098. [PubMed: 10331101] 
Rhinn H, Qiang L, Yamashita T, Rhee D, Zolin A, Vanti W, Abeliovich A. Alternative alpha-
synuclein transcript usage as a convergent mechanism in Parkinson’s disease pathology. Nat 
Commun. 2012; 3:1084. [PubMed: 23011138] 
Salzman, S.; Endicott, J.; Clayton, P.; Winokur, G. Diagnostic evaluation after death (DEAD). 
Rockville, MD: National Institute of Mental Health, Neuroscience Research Branch; 1983. 
Scorticati C, Formoso K, Frasch AC. Neuronal glycoprotein M6a induces filopodia formation via 
association with cholesterol-rich lipid rafts. J Neurochem. 2011
Segal M. Dendritic spines and long-term plasticity. Nat Rev Neurosci. 2005; 6:277–284. [PubMed: 
15803159] 
Sequeira A, Klempan T, Canetti L, ffrench-Mullen J, Benkelfat C, Rouleau GA, Turecki G. Patterns of 
gene expression in the limbic system of suicides with and without major depression. Mol 
Psychiatry. 2007; 12:640–655. [PubMed: 17353912] 
Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, Rehal S, Klempan T, Gratton A, 
Benkelfat C, Rouleau GA, Mechawar N, Turecki G. Global brain gene expression analysis links 
glutamatergic and GABAergic alterations to suicide and major depression. PLoS One. 2009; 
4:e6585. [PubMed: 19668376] 
Spitzer, R.; Williams, J.; Gibbon, M.; First, M. Structural clinical interview for DSM-IV (SCID). New 
York, NY: New York State Psychiatric Institute Biometrics Research; 1995. 
Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB, 
Friedman L, Rajkowska G. Cellular changes in the postmortem hippocampus in major depression. 
Biol Psychiatry. 2004; 56:640–650. [PubMed: 15522247] 
FUCHSOVA et al. Page 17
Neuroscience. Author manuscript; available in PMC 2016 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Svitkina T, Lin WH, Webb DJ, Yasuda R, Wayman GA, Van Aelst L, Soderling SH. Regulation of the 
postsynaptic cytoskeleton: roles in development, plasticity, and disorders. J Neurosci. 2010; 
30:14937–14942. [PubMed: 21068295] 
Tiraboschi E, Giambelli R, D’Urso G, Galietta A, Barbon A, de Bartolomeis A, Gennarelli M, Barlati 
S, Racagni G, Popoli M. Antidepressants activate CaMKII in neuron cell body by Thr286 
phosphorylation. Neuroreport. 2004; 15:2393–2396. [PubMed: 15640762] 
van Heeringen C. Suicide, serotonin, and the brain. Crisis. 2001; 22:66–70. [PubMed: 11727896] 
van Veen T, Goeman JJ, Monajemi R, Wardenaar KJ, Hartman CA, Snieder H, Nolte IM, Penninx 
BW, Zitman FG. Different gene sets contribute to different symptom dimensions of depression 
and anxiety. Am J Med Genet B Neuropsychiatr Genet. 2012; 159B:519–528. [PubMed: 
22573416] 
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate 
normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal 
control genes. Genome Biol. 2002; 3:RESEARCH0034. [PubMed: 12184808] 
Vidal M, Cusick ME, Barabasi AL. Interactome networks and human disease. Cell. 2011; 144:986–
998. [PubMed: 21414488] 
Webb DJ, Zhang H, Majumdar D, Horwitz AF. Alpha5 integrin signaling regulates the formation of 
spines and synapses in hippocampal neurons. J Biol Chem. 2007; 282:6929–6935. [PubMed: 
17213186] 
Werner HB, Kramer-Albers EM, Strenzke N, Saher G, Tenzer S, Ohno-Iwashita Y, De Monasterio-
Schrader P, Mobius W, Moser T, Griffiths IR, Nave KA. A critical role for the cholesterol-
associated proteolipids PLP and M6B in myelination of the central nervous system. Glia. 2013; 
61:567–586. [PubMed: 23322581] 
Wu GY, Cline HT. Stabilization of dendritic arbor structure in vivo by CaMKII. Science. 1998; 
279:222–226. [PubMed: 9422694] 
Xing G, Russell S, Hough C, O’Grady J, Zhang L, Yang S, Zhang LX, Post R. Decreased prefrontal 
CaMKII alpha mRNA in bipolar illness. Neuroreport. 2002; 13:501–505. [PubMed: 11930170] 
Yan Y, Narayanan V, Lagenaur C. Expression of members of the proteolipid protein gene family in 
the developing murine central nervous system. J Comp Neurol. 1996; 370:465–478. [PubMed: 
8807448] 
Zappia MP, Bernabo G, Billi SC, Frasch AC, Ceriani MF, Brocco MA. A role for the membrane 
protein M6 in the Drosophila visual system. BMC Neurosci. 2012; 13:78. [PubMed: 22762289] 
Zhang H, Webb DJ, Asmussen H, Horwitz AF. Synapse formation is regulated by the signaling 
adaptor GIT1. J Cell Biol. 2003; 161:131–142. [PubMed: 12695502] 
Zhang H, Webb DJ, Asmussen H, Niu S, Horwitz AF. A GIT1/PIX/Rac/PAK signaling module 
regulates spine morphogenesis and synapse formation through MLC. J Neurosci. 2005; 25:3379–
3388. [PubMed: 15800193] 
Zhang YP, Holbro N, Oertner TG. Optical induction of plasticity at single synapses reveals input-
specific accumulation of alphaCaMKII. Proc Natl Acad Sci U S A. 2008; 105:12039–12044. 
[PubMed: 18697934] 
Zhao J, Iida A, Ouchi Y, Satoh S, Watanabe S. M6a is expressed in the murine neural retina and 
regulates neurite extension. Mol Vis. 2008; 14:1623–1630. [PubMed: 18776950] 
Zhurov V, Stead JD, Merali Z, Palkovits M, Faludi G, Schild-Poulter C, Anisman H, Poulter MO. 
Molecular pathway reconstruction and analysis of disturbed gene expression in depressed 
individuals who died by suicide. PLoS One. 2012; 7:e47581. [PubMed: 23110080] 
FUCHSOVA et al. Page 18
Neuroscience. Author manuscript; available in PMC 2016 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Highlights
• GPM6A and GPM6B are transcriptionally downregulated in the hippocampus of 
depressed suicides.
• Neuroplasticity-related proteins that form complexes with GPM6A were 
identified.
• mRNA of the components of GPM6A complexes is decreased in the depressed 
group.
• Coexpression pattern analysis demonstrates coordinated gene expression in the 
brain.
• In the brain of depressed suicides this coordinated response is disrupted.
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Fig. 1. 
(A) Correlation studies to evaluate reproducibility of reverse transcription (RT) reaction. 
Equal amounts of RNA extracted from eight samples were reverse transcribed in two 
independent RT reactions (1st RT and 2nd RT) and used as a template for qPCR to measure 
twice the expression of GPM6A and PPIA. Both genes show a statistically significant 
correlation (GPM6A Pearson coefficient=0.7702, *p value (two-tailed)=0.0254; PPIA 
Pearson coefficient=0.7452, *p value (two-tailed)=0.0339). (B) Correlation studies to 
evaluate inter-run reproducibility qPCR reaction. Two identical replica plates containing 
eight cDNA samples obtained from 1st RT reaction were prepared and used to measure the 
expression of GPM6A and PPIA in two independent runs. Both genes show a statistically 
significant correlation (GPM6A Pearson coefficient=0.9882, ***p value (two-tailed)< 
0.0001; PPIA Pearson coefficient=0.8709, **p value (two-tailed)=0.0049). (C) Efficiency 
data for candidate reference genes and target genes. CT values obtained from 10-fold serial 
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dilutions of cDNA were plotted against dilution factors and the reaction efficiency was 
calculated using qBasePLUS software. RT, reverse transcription; CT, treshold cycle; RSq, r-
squared; Rn, normalized reporter signal; dRn, delta Rn (Rn minus the baseline); Tm, melting 
temperature.
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Fig. 2. 
Expression stability of five candidate reference genes in human brain samples calculated by 
geNorm algorithm using qBasePLUS software (Biogazelle). GeNorm analysis was 
performed on the gene expression data from PFC and hippocampal postmortem samples 
obtained from all depressed suicide subjects and matched nonpsychiatric controls. (A) 
Average expression stability values (M) of five candidate genes from the least stable to the 
most stable in PFC. The gene stability measure M is defined as the average pairwise 
variation of a particular gene with all other control genes (Vandesompele et al., 2002). 
Genes with lowest values have the most stable expression (optimal geNorm M ≤ 0.5). In the 
PFC samples, the geNorm gene stability measurement values M were ranked in the 
following order (from the least to the most stable): YWHAZ, EIF4A2, GAPDH, CYC1, and 
PPIA. (B) Determination of the optimum number of reference genes required for adequate 
data normalization based on pairwise variation (Vn/Vn+1) between candidate genes in the 
PFC (optimal geNorm V<0.15). Normalization to a single control gene can lead to erroneous 
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normalization. For this reason, geNorm also calculates the pairwise variation value (Vn/n+1) 
that shows the effect of adding further reference genes on the normalization factor. When 
analyzing Vn/n+1, we observed that the stepwise inclusion of individual reference genes 
showed a decrease until a minimal value (V3/4). The next addition of other reference gene 
determined an increase of V4/5, suggesting that there was a decrease of expression stability 
due to the inclusion of a relatively unstable fifth gene. Thus, the adequate number of 
reference targets in this experimental situation is three when comparing a normalization 
factor based on three or four most stable targets. (C) Reference target stability values (M and 
CV) determined for the combination of the reference targets GAPDH, CYC1, and PPIA in 
human brain samples from the PFC and hippocampus. To assess that the genes with the 
lowest M values have indeed the most stable expression, the gene-specific variation of each 
control gene is determined as the variation coefficient (CV) of the expression levels after 
normalization. Mean CV values lower than 0.2 are typically observed for stably expressed 
reference genes in relatively homogenous sample panels. As such, in human postmortem 
PFC and hippocampal samples, the optimal normalization factor can be calculated as the 
geometric mean of reference targets PPIA, CYC1, and GAPDH. (D) Expression levels of 
reference genes GAPDH, PPIA andCYC1 in the PFC and in the hippocampus of non-
psychiatric controls (Control: PFC n=25 for PPIA and CYC1, n=24 for GAPDH; 
Hippocampus n=18 for GAPDH, PPIA and CYC1) and depressed (Depressed: PFC n=25 for 
GAPDH, PPIA and CYC1; Hippocampus n=18 for GAPDH, PPIA and CYC1) suicide 
subjects. Results are expressed as fold change in mRNA levels. Values are fold change±SD. 
No significant differences between the depressed suicide group and the control group were 
determined for any of the genes. (E) Expression levels of BDNF in the PFC and in the 
hippocampus of non-psychiatric controls (Control: PFC n=25, Hippocampus n=18) and 
depressed (Depressed: PFC n=24, Hippocampus n=16) suicide subjects. Results are 
expressed as fold change in mRNA levels. Values are fold change±SD. BDNF mRNA levels 
were significantly decreased in the depressed subjects compared with controls in both the 
PCF and the hippocampus (F=16.39, p=0.0001, and F=12.65, p=0.0006, respectively). 
Significant effects are marked by asterisks (Bonferroni corrected significance threshold, 
after correction: asterisk, P<0.05; two asterisks, P<0.01).
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Fig. 3. 
mRNA levels of GPM6A, GPM6B, and PLP1 in PFC (A) and in the hippocampus (B) of 
non-psychiatric controls (Control: PFC n=25 for GPM6A, GPM6B, and PLP1; 
Hippocampus n=18 for GPM6A and GPM6B, n=17 for PLP1) and depressed (Depressed: 
PFC n=25 for GPM6A and GPM6B, n=24 for PLP1; Hippocampus n=17 for GPM6A and 
PLP1, n=16 for GPM6B) suicide subjects normalized to the geometric mean of the three 
reference targets (GAPDH, CYC1, PPIA). Results are expressed as fold change in mRNA 
levels. Values are fold change±SD. Significant differences between the depressed suicides 
and the control group were determined for GPM6A (F=14.55, p=0.0002) and GPM6B 
(F=12.98, p=0.0005) in the hippocampal tissue. Significant effects are marked by asterisks 
(Bonferroni corrected significance threshold, after correction: asterisk, P<0.05; two 
asterisks, P<0.01).
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Fig. 4. 
(A) Polyclonal antibody against C-terminus of GPM6A specifically recognizes endogenous 
as well as exogenous GPM6A protein. Western blot analysis of lysates from adult rat 
hippocampus (Hipp) and from non-neuronal cell line COS7 overexpressing exogenous 
GPM6A as a GFP fusion protein (COS7) shows a protein migrating at ~35 kDa (1st lane) 
corresponding to endogenous GPM6A and a protein migrating at ~62 kDa (3rd lane) 
corresponding to exogenous GPM6A overexpressed as a GFP fusion protein (COS7). No 
additional nonspecific bands were detected. No signal was detected when COS7 cells were 
transfected with GFP alone (2nd lane). The polyclonal anti-GFP antibody recognizes both 
GPM6A-GFP as well as GFP when overexpressed in COS7 cells (4th and 5th lane 
respectively). (B) SDS-PAGE analysis of proteins co-immunoprecipitating with GPM6A. 
The endogenous GPM6A was immunoprecipitated from adult rat hippocampus using the 
polyclonal antibody against C-terminal end of GPM6A coupled to protein A-Sepharose 
(lane 2). As a control nonimmune rabbit serum covalently coupled to protein A–Sepharose 
was used (lane 1). Coimmunoprecipitating proteins were visualized by silver staining 
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technique compatible with mass spectrometry. The proteins of interest were excised from 
the gel, subjected to tryptic digest and analyzed by mass spectrometry. G protein-coupled 
receptor kinase-interacting protein 1 (GIT1), coronin-1A (CORO1A), and calcium/
calmodulin-dependent protein kinase 2 aplha (CAMK2A) were identified among proteins 
that coimmunoprecipitate with GPM6A (arrows). (C) Complete list of proteins co-
immunoprecipitating with GPM6A as identified by mass spectrometry.
FUCHSOVA et al. Page 26
Neuroscience. Author manuscript; available in PMC 2016 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 5. 
mRNA levels of CORO1A, GIT1, and CAMK2A in the PFC (A) and in the hippocampus (B) 
of non-psychiatric controls (Control: PFC n=25 for CORO1A, GIT1, and CAMK2A; 
Hippocampus n=18 for CORO1A, GIT1, and CAMK2A) and depressed (Depressed: PFC 
n=25 for CORO1A, GIT1, and CAMK2A; Hippocampus n=18 for CORO1A and GIT1, n=17 
for CAMK2A) suicide subjects normalized to the geometric mean of the three reference 
targets (GAPDH, CYC1, PPIA). Results are expressed as fold change in mRNA levels. 
Values are fold change±SD. Significant differences between the depressed suicide group 
and the control group were determined for CORO1A and for CAMK2A in the hippocampal 
tissue (F=25.45, p<0.0001, and F =18.47, p<0.0001; respectively). Significant effects are 
marked by asterisks (Bonferroni corrected significance threshold, after correction: asterisk, 
P <0.05; two asterisks, P<0.01).
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Fig. 6. 
Coordinated expression is decreased in the brain of depressed suicides. (A) Correlation 
analysis of mRNA expression levels in the PFC and in the hippocampus. In the matrix all 
pairwise Pearson correlation coefficients calculated on normalized mRNA expression levels 
are shown. Statistically significant Pearson correlation p values (two-tailed) are indicated by 
asterisks (*<0.05, **<0.01, ***<0.001, ns=no significant; dark gray indicates a statistically 
significant correlation, light gray indicates a non significant correlation). In suicide brain 
(lower portion of the correlation matrix) significant correlations appear less frequently than 
in controls (upper portion of the correlation matrix). Decrease in the frequency of significant 
correlations between controls and depressed suicides is statistically significant in the 
hippocampus (chi-square=6.136, *p=0.013; in PFC chi-square=2.143, p=0.1432). (B) 
Network of the gene coexpression pattern in the PFC and in the hippocampus in control and 
depressed groups. Gene pairs that show a significant correlation are indicated: a positive 
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significant correlation (full line); a negative significant correlation (dashed line). Dark 
circles indicate differentially expressed genes. Differences between control and depressed 
groups are observed in both tissues.
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